Non-synaptically released oxytocin regulates social communication by acting on vasopressin V1a receptors.
Aspesi. Dario D; Walton. James C JC; Grieb. Zachary A ZA; Kirchner. Matthew K MK; Song. Zhimin Z; Long. Madeline R MR; Larkin. Tony E TE; Stern. Javier E JE; Albers. H Elliott HE
Key Findings
- α‑MSH triggers non‑synaptic release of oxytocin but not vasopressin
- Oxytocin released this way activates vasopressin V1a receptors to increase scent marking
- Blocking V1a receptors, not oxytocin receptors, reduces the scent‑marking response
Practical Outcomes
- For DIY health enthusiasts, the study suggests that oxytocin’s social effects might be modulated via vasopressin V1a receptors, hinting that compounds targeting V1a could influence social behavior. However, the work is in hamsters and offers no direct dosing or protocol advice for humans.
Summary
Scientists found that in hamsters, a hormone called oxytocin can be released in a non‑synaptic way and then works through a different receptor (the vasopressin V1a receptor) to boost scent‑marking, a social behavior. This shows oxytocin’s effects aren’t limited to its own receptor and that the V1a pathway matters for certain social actions.
Abstract
How neuropeptides act within the neural circuits that control social behavior is not well understood. While the prevailing view is that neuropeptides act through synaptic release and then activation of their canonical receptors on postsynaptic membranes, we investigated the role of a very different form of neuropeptide action in a neural circuit regulating social communication. Specifically, we tested the hypothesis that non-synaptically released oxytocin (OT) can act via the non-canonical receptors vasopressin V1a receptors (V1aR) to regulate social communication in Syrian hamsters. Scent marking, a key form of hamster social communication, can be enhanced by the α-melanocortin stimulating hormone (α-MSH), which stimulates OT but not arginine-vasopressin (AVP) release. Here, we employed hypothalamic injections of α-MSH and the α-MSH MC4R receptor antagonist MCL-0020 to determine the role of α-MSH in the expression of flank marking. To determine if these effects were intracellular calcium (iCa<sup>2+</sup>) dependent, hamsters were injected with AVP to induce flank marking and with the iCa<sup>2+</sup> antagonist TMB-8 to test whether it was possible to block this behavioral effect. Further, a highly selective AVP V1a receptor (V1aR) antagonist and an OT receptor (OTR) antagonist were injected into the hypothalamus to investigate the receptor responsible for activating flank marking. Finally, we employed an in vitro hypothalamic slice preparation using "Sniffer cells" biosensors to confirm that α-MSH induced the release of OT but not AVP. First, we found that the in vivo hypothalamic injection of α-MSH increased odor-stimulated scent marking, whereas blockade of its receptor with MCL-0020 reduced this behavior. Hypothalamic infusion of the iCa<sup>2+</sup> antagonist TMB-8 significantly reduced both AVP-induced and α-MSH-induced flank marking. Moreover, only the V1aR antagonist, and not the OTR antagonist, significantly decreased scent marking in response to hypothalamic infusion of α-MSH. Finally, biosensor recordings from hypothalamic slices confirmed that α-MSH stimulates OT, but not AVP, release. Together, these results demonstrate that α-MSH triggers non-synaptic OT release that regulates scent marking via V1aR activation, revealing a novel mechanism by which neuropeptides modulate social behavior.
Study Information
pubmed
2025
2025-11-17T00:00:00.000Z
10.1111/jne.70111
7